EX-99 2 a04-12022_1ex99.htm EX-99

Exhibit 99

 

 

NEWS RELEASE

 

SILICON LABORATORIES REPORTS THIRD QUARTER RESULTS

 

AUSTIN, Texas – Oct. 25, 2004 – Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal ICs, today reported revenue of $121.0 million for the third quarter of 2004 and earnings per share of $0.39.

 

Financial Results

 

Revenue for the third quarter increased 46 percent over $82.9 million for the same period in 2003. Under generally accepted accounting principles (GAAP), operating income for the third quarter was $30.4 million, or 25.1 percent of revenues. Third quarter net income was $21.0 million. Excluding non-cash charges for amortization of deferred stock compensation, adjusted net income for the third quarter was $22.0 million and adjusted diluted net income per share was $0.40. The company’s cash and short-term investments increased eight percent to $241 million. The reconciling charges are set forth in the reconciliation of GAAP to non-GAAP financial measures table included below.

 

Business Summary

 

“I am very pleased to report that we achieved our target operating model for the ninth consecutive quarter,” said Dan Artusi, president and chief executive officer of Silicon Laboratories. “We identified and began addressing changes in the wireless market early in the quarter demonstrating the company’s nimbleness. The growing diversity of our product portfolio and customer base also contributed to our business performance.”

 

Silicon Laboratories’ broad-based mixed-signal businesses performed well during the quarter, with revenue growing sequentially by 11 percent due to strength in ProSLIC® telephony ICs, ISOmodem® embedded modems and microcontroller products. As expected, mobile handset

 

-more-

 



 

 

revenue declined sequentially. However, handset design win activity hit a record high and included next generation products.

 

Business Outlook

 

“We are taking a very cautious view on the industry in the fourth quarter. We believe that uncertainty in the outlook for the world’s economy along with an excess of semiconductor supply will result in softness in the major markets we serve,” Mr. Artusi added. “We believe that it will take time for our customers to bring the supply chain into balance and for end market demand visibility to improve.”

 

The company anticipates revenue of $93 to $97 million in the fourth quarter of 2004.

 

Conference Call Today

 

A conference call discussing the third quarter results will follow the release at 4:15 p.m. Eastern Time. An audio webcast will be available simultaneously on Silicon Laboratories’ website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 866-470-8786 (U.S.) or +1 203-369-1489 (international). These replays will be available through November 25, 2004.

 

About Silicon Laboratories Inc.

 

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories’ diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with decades of cumulative expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories please visit www.silabs.com.

 

Cautionary Language

 

This press release contains forward-looking statements based on Silicon Laboratories’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Laboratories are intended to

 



 

identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease rapidly; dependence on a limited number of products and customers; difficulties developing new products that achieve market acceptance; risks that Silicon Labs may not be able to manage strains associated with its growth; difficulties managing our manufacturers and subcontractors; difficulties managing international activities; credit risks associated with our accounts receivable; geographic concentration of manufacturers, assemblers, test service providers and customers in the Pacific Rim that subjects Silicon Laboratories’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; product development risks; inventory-related risks; intellectual property litigation risks; risks associated with acquisitions, including the acquisition of Cygnal Integrated Products; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories filings with the SEC, including the Form 10-Q that we anticipate will be filed on or about October 25, 2004. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Note to editors: Silicon Laboratories, ProSLIC, ISOmodem and the Silicon Laboratories logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Silicon Laboratories Inc., Shannon Pleasant, 512/464-9254 investor.relations@silabs.com

 



 

Silicon Laboratories Inc.

Unaudited Condensed Consolidated Statements of Income

(in thousands, except per share data)

 

 

 

THREE MONTHS ENDED

 

NINE MONTHS ENDED

 

 

 

OCTOBER 2,
2004

 

SEPTEMBER 27,
2003

 

OCTOBER 2,
2004

 

SEPTEMBER 27,
2003

 

Revenues

 

$

121,010

 

$

82,907

 

$

360,763

 

$

215,746

 

Cost of revenues

 

53,712

 

38,061

 

163,122

 

111,906

*

Gross profit

 

67,298

 

44,846

 

197,641

 

103,840

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

18,856

 

12,267

 

54,865

 

33,433

 

Selling, general and administrative

 

17,058

 

10,688

 

48,912

 

30,223

 

Amortization of deferred stock compensation

 

983

 

1,196

 

3,383

 

3,686

 

Operating expenses

 

36,897

 

24,151

 

107,160

 

67,342

 

Operating income

 

30,401

 

20,695

 

90,481

 

36,498

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

790

 

281

 

1,860

 

933

 

Interest expense

 

(78

)

 

(243

)

 

Other income (expense), net

 

(29

)

75

 

1,979

 

(707

)

Income before income taxes

 

31,084

 

21,051

 

94,077

 

36,724

 

Provision for income taxes

 

10,041

 

7,119

 

30,313

 

12,931

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

21,043

 

$

13,932

 

$

63,764

 

$

23,793

 

Net income per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.41

 

$

0.28

 

$

1.25

 

$

0.49

 

Diluted

 

$

0.39

 

$

0.26

 

$

1.16

 

$

0.46

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

51,389

 

48,939

 

51,124

 

48,545

 

Diluted

 

54,547

 

52,816

 

54,930

 

51,709

 

 


* Includes a $15.3 million charge for a patent infringement litigation settlement

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(in thousands, except per share data)

 

 

 

THREE MONTHS ENDED

 

NINE MONTHS ENDED

 

 

 

OCTOBER 2,
2004

 

SEPTEMBER 27,
2003

 

OCTOBER 2,
2004

 

SEPTEMBER 27,
2003

 

GAAP net income

 

$

21,043

 

$

13,932

 

$

63,764

 

$

23,793

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

Settlement of patent infringement lawsuit, net of tax

 

 

 

 

10,377

 

Amortization of deferred stock compensation

 

983

 

1,196

 

3,383

 

3,686

 

Adjusted net income

 

$

22,026

 

$

15,128

 

$

67,147

 

$

37,856

 

 

 

 

 

 

 

 

 

 

 

GAAP diluted shares outstanding

 

54,547

 

52,816

 

54,930

 

51,709

 

 

 

 

 

 

 

 

 

 

 

Adjusted diluted net income per share

 

$

0.40

 

$

0.29

 

$

1.22

 

$

0.73

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

 

 

 

OCTOBER 2,
2004

 

JANUARY 3,
2004

 

 

 

(UNAUDITED)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

180,422

 

$

151,359

 

Short-term investments

 

60,324

 

38,954

 

Accounts receivable, net of allowance for doubtful accounts of $1,638 at October 2, 2004 and $1,079 at January 3, 2004

 

77,802

 

47,879

 

Inventories

 

38,825

 

34,064

 

Deferred income taxes

 

5,784

 

5,784

 

Prepaid expenses and other

 

4,998

 

5,600

 

Total current assets

 

368,155

 

283,640

 

Property, equipment and software, net

 

37,026

 

34,376

 

Goodwill

 

38,721

 

38,613

 

Other intangible assets, net

 

16,021

 

14,744

 

Other assets, net

 

10,215

 

6,722

 

Total assets

 

$

470,138

 

$

378,095

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

42,360

 

$

45,488

 

Accrued expenses

 

15,492

 

11,251

 

Deferred income on shipments to distributors

 

23,914

 

11,526

 

Income taxes payable

 

10,320

 

12,663

 

Total current liabilities

 

92,086

 

80,928

 

Long-term obligations

 

7,561

 

9,962

 

Total liabilities

 

99,647

 

90,890

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock—$.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$.0001 par value; 250,000 shares authorized; 51,935 and 51,237 shares issued and outstanding at October 2, 2004 and January 3, 2004, respectively

 

5

 

5

 

Additional paid-in capital

 

272,697

 

256,792

 

Deferred stock compensation

 

(5,641

)

(9,257

)

Retained earnings

 

103,430

 

39,665

 

Total stockholders’ equity

 

370,491

 

287,205

 

Total liabilities and stockholders’ equity

 

$

470,138

 

$

378,095

 

 

# # #